Herborium Group, Inc.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a HBRM research report →
Companywww.herborium.com
Herborium Group, Inc. , a botanical therapeutics company, develops, licenses, and markets proprietary, botanical based medicinal products to consumers and healthcare professionals. It offers dermatology products, which include AcnEase, herbal medicinal product for enhancing conditions associated with hormonal acne and multiple symptoms of Rosacea; and AcnEase Skin Management System for the treatment of acne marks/scars.
- CEO
- Agnes Olszewski
- IPO
- 1998
- Employees
- 2
- HQ
- Fort Lee, NJ, US
Price Chart
Valuation
- Market Cap
- $109.19K
- P/E
- -0.49
- P/S
- 0.13
- P/B
- -0.03
- EV/EBITDA
- -4.15
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 61.12%
- Op Margin
- -34.13%
- Net Margin
- -26.93%
- ROE
- 5.80%
- ROIC
- 9.74%
Growth & Income
- Revenue
- $788.25K · -25.00%
- Net Income
- $-154,770 · 52.92%
- EPS
- $0.00 · 0.00%
- Op Income
- $-238,000
- FCF YoY
- 0.00%
Performance & Tape
- 52W High
- $0.00
- 52W Low
- $0.00
- 50D MA
- $0.00
- 200D MA
- $0.00
- Beta
- 8.81
- Avg Volume
- 679.11K
Get TickerSpark's AI analysis on HBRM
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our HBRM Coverage
We haven't published any research on HBRM yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate HBRM Report →